Merz Gets 2 More Months To Block Generic MS Drug
Pharmaceutical giant Merz has won an injunction from Europe's patent court to stop generic drugmaker Viatris Santé from selling a multiple sclerosis treatment in France for two more months while Merz's...To view the full article, register now.
Already a subscriber? Click here to view full article